Evidence map›Paper›PMID 35783295›Full record

ArticleNature reviews. Chemistry2022

CACHE (Critical Assessment of Computational Hit-finding Experiments): A public-private partnership benchmarking initiative to enable the development of computational methods for hit-finding.

Suzanne Ackloo, Rima Al-Awar, Rommie E Amaro, Cheryl H Arrowsmith, Hatylas Azevedo, Robert A Batey, Yoshua Bengio, Ulrich A K Betz, Cristian G Bologa, John D Chodera and 31 more

Open access · hybridAbstract read
In one paragraph

Article in Nature reviews. Chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
12.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 92 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Blind Challenges Let Us See the Path Forward for Predictive Models.Journal of chemical information and modeling · 2026
    Article
  16. CACHE Challenge #3: Targeting the Nsp3 Macrodomain of SARS-CoV-2.Journal of chemical information and modeling · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors at 20 institutions in 7 countries.

Suzanne AcklooStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Rima Al-AwarOntario Institute for Cancer Research, Toronto, Ontario, Canada.
Rommie E AmaroDepartment of Chemistry and Biochemistry, UC San Diego, La Jolla, CA, USA.
Cheryl H ArrowsmithStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Hatylas AzevedoAché Laboratórios Farmacêuticos, Guarulhos, São Paulo, Brazil.
Robert A BateyDepartment of Chemistry, University of Toronto, Toronto, Ontario, Canada.
Yoshua BengioMila, University of Montreal, Québec, Canada.
Ulrich A K BetzMerck Healthcare KGaA, Darmstadt, Germany.
Cristian G BologaDepartment of Internal Medicine, University of New Mexico School of Medicine, University of New Mexico Albuquerque, Albuquerque, NM, USA.
John D ChoderaComputational and Systems Biology Program Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Wendy D CornellHealthcare & Life Sciences Research, IBM TJ Watson Research Center, New York, USA.
Ian DunhamEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, UK.
Gerhard F EckerDepartment of Pharmaceutical Sciences, University of Vienna, Vienna, Austria.
Kristina EdfeldtStructural Genomics Consortium, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
Aled M EdwardsStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Michael K GilsonDrug Design Data Resource, University of California, San Diego, La Jolla, CA, USA.
Claudia R GordijoStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Gerhard HesslerSanofi-Aventis Deutschland GmbH, R&D, Integrated Drug Discovery, Frankfurt am Main, Germany.
Alexander HillischBayer AG, Pharmaceuticals, Research and Development, Wuppertal, Germany.
Anders HognerMedicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
John J IrwinDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.
Johanna M JansenNovartis Institutes for BioMedical Research, Emeryville, CA, USA.
Daniel KuhnMerck Healthcare KGaA, Computational Chemistry & Biologics, Darmstadt, Germany.
Andrew R LeachEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, UK.
Alpha A LeePostEra Inc, San Franciso, CA, USA.
Uta LesselBoehringer Ingelheim Pharma GmbH & Co. KG, Medicinal Chemistry, Biberach an der Riss, Germany.
Maxwell R MorganStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
John MoultInstitute for Bioscience and Biotechnology Research, Rockville, MD, USA.
Ingo MueggeAlkermes, Inc., Waltham, MA, USA.
Tudor I OpreaDepartment of Internal Medicine, University of New Mexico School of Medicine, University of New Mexico Albuquerque, Albuquerque, NM, USA.
Benjamin G PerryDrugs for Neglected Diseases initiative, Geneva, Switzerland.
Patrick RileyRelay Therapeutics, Boston, MA, USA.
Sophie A L RousseauxDepartment of Chemistry, University of Toronto, Toronto, Ontario, Canada.
Kumar Singh SaikatenduGlobal Research Externalization, Takeda California, Inc., San Diego, CA, USA.
Vijayaratnam SanthakumarStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Matthieu SchapiraStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Cora ScholtenBayer AG, Pharmaceuticals, Open Innovation - Public Private Partnerships, Berlin, Germany.
Matthew H ToddSchool of Pharmacy, University College London, London, UK.
Masoud VedadiStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Andrea VolkamerIn Silico Toxicology and Structural Bioinformatics, Institute of Physiology, Charité Universitätsmedizin Berlin, Berlin, Germany.
Timothy M WillsonStructural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
University of Toronto · CABayer (Germany) · DEEuropean Bioinformatics Institute · GBMerck (Germany) · DEUniversity of California San Diego · USUniversity of New Mexico · USAlkermes (United States) · USAstraZeneca (Sweden) · SEBoehringer Ingelheim (Germany) · DECharité - Universitätsmedizin Berlin · DEDrugs for Neglected Diseases Initiative · CHIBM (United States) · USInstitute for Bioscience and Biotechnology ResearchKarolinska University Hospital · SEMemorial Sloan Kettering Cancer Center · USMila - Quebec Artificial Intelligence Institute · CANovartis (United States) · USOntario Institute for Cancer Research · CARelay Therapeutics (United States) · USSanofi (Germany) · DE

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
THEORY AND MODELING OF NONCOVALENT BINDINGR01GM061300 · NIGMS · UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE · PI GILSON, MICHAEL K. · 2000 to 2021
$7.2M
Machine Learning Model Validation for AD/ADRDU24CA224370 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI EDWARDS, JEREMY S · 2018 to 2023
$6.4M
Resource Dissemination and Outreach Center for Illuminating the Druggable GenomeU24TR002278 · NCATS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SCHURER, STEPHAN C, SKLAR, LARRY A. · 2018 to 2023
$3.7M
Ultra-large library docking for ligand discoveryR01GM133836 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI IRWIN, JOHN J. · 2019 to 2022
$1.6M
Advancing predictive physical modeling through focused development of model systems to drive new modeling innovationsR01GM124270 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI MOBLEY, DAVID LOWELL · 2018 to 2021
$1.5M
NCATS NIH HHS U24 TR002278NCI NIH HHS P30 CA008748NCI NIH HHS U24 CA224370NIGMS NIH HHS R01 GM061300NIGMS NIH HHS R01 GM124270NIGMS NIH HHS R01 GM133836
6 · The paper itself

Abstract

One aspirational goal of computational chemistry is to predict potent and drug-like binders for any protein, such that only those that bind are synthesized. In this Roadmap, we describe the launch of Critical Assessment of Computational Hit-finding Experiments (CACHE), a public benchmarking project to compare and improve small molecule hit-finding algorithms through cycles of prediction and experimental testing. Participants will predict small molecule binders for new and biologically relevant protein targets representing different prediction scenarios. Predicted compounds will be tested rigorously in an experimental hub, and all predicted binders as well as all experimental screening data, including the chemical structures of experimentally tested compounds, will be made publicly available, and not subject to any intellectual property restrictions. The ability of a range of computational approaches to find novel binders will be evaluated, compared, and openly published. CACHE will launch 3 new benchmarking exercises every year. The outcomes will be better prediction methods, new small molecule binders for target proteins of importance for fundamental biology or drug discovery, and a major technological step towards achieving the goal of Target 2035, a global initiative to identify pharmacological probes for all human proteins.

Identifiers

PMID35783295
PMCPMC9246350
OpenAlexW4283835519

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.